Status:
UNKNOWN
Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage
Lead Sponsor:
Erzincan Military Hospital
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
20-40 years
Phase:
PHASE4
Brief Summary
In the aetiology of postpartum uterine atony, hypoxia is considered an important factor although some suggest that peripheral oxygen saturation is not influenced by oxygen inhalation in women during t...
Eligibility Criteria
Inclusion
- gestational age between 37 and 42 weeks;
- singleton pregnancy;
- live fetus;
- cephalic presentation;
- neonatal birth weight of 2500-4500 g;
- parity between one and five;
- maternal age \< 35 years old;
- vaginal birth
Exclusion
- blood pressure ≥ 140/90mmHg;
- placenta previa;
- placental abruption;
- a history of any bleeding during pregnancy;
- a history of curettage;
- cesarean section or any uterine scar;
- a history of postpartum hemorrhage;
- polyhydramnios;
- signs or symptoms of maternal infection;
- known uterine anomalies;
- history of any drug use during labor;
- abnormal placentation;
- coagulation defects;
- instrumental deliveries;
- hemoglobin concentration \< 8 g/dL;
- history of anticoagulant drugs;
- beta-mimetic medications during pregnancy;
- prolongation of the first stage of labor \> 15 hours
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT01180192
Start Date
May 1 2010
End Date
September 1 2010
Last Update
February 14 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bakirkoy Women's and Children's Teaching Hospital
Istanbul, Turkey (Türkiye)